Search

Dyspareunia, or painful sexual intercourse, associated with menopause has been a taboo subject for decades. During the past year, postmenopausal women have been saturated with print and television advertisements regarding two prescription treatments for painful sex associated with menopause. This book is intended to elucidate in understandable terms the two prescription options currently available for the treatment of dyspareunia, Premarin® (conjugated equine estrogens) Vaginal Cream and Osphena™ (ospemifene) oral tablets. Premarin® is a cocktail of hormones isolated from the urine of pregnant horses that was originally approved by the U.S. Food and Drug Administration (FDA) for the treatment of menopausal symptoms in 1942. Today, Premarin® remains the most commonly prescribed hormone replacement therapy (HRT). Osphena™ is a synthetic non-estrogen drug approved in 2013 that is classified as a selective estrogen receptor modulator (SERM). Other SERMs approved by the FDA include tamoxifen for breast cancer treatment and prevention, and Evista® (raloxifene) for the prevention of postmenopausal osteoporosis and reducing the risk of breast cancer. The FDA is required to educate the public about the benefits and risks of prescription drugs. Unfortunately, these messages are not always clear. We discuss, in understandable terms, the benefits and risks of Premarin® Vaginal Cream and Osphena™ oral tablets as seen in media advertisements, boxed warnings and package inserts. Throughout this book, we discuss the history of these two treatment options for dyspareunia and the future research intended to improve upon hormone replacement therapy for postmenopausal women.

Hepatitis C Doesn't Have to Be a Lifelong IllnessCuring Hepatitis C provides the latest information to guide you through the diagnosis and treatment of hepatitis C. If you or a loved one has been diagnosed with hepatitis C, this book provides an indispensable and comprehensive overview of everything you need to know to take the right steps toward a cure.For the nearly 160 million people worldwide and 4 million Americans diagnosed with hepatitis C, there is now hope. Although hepatitis C was once considered incurable, medical and technological innovations have made a cure possible. A new frontier of treatment options has improved upon previous methods by curbing side-effects more effectively and working to eradicate hepatitis C entirely. Curing Hepatitis C also includes:• Easy-to-understand explanations of the nature of hepatitis C • The revealing truth of misconceptions about hepatitis C • Tips to prevent, diagnose, cope with, and ultimately cure this disease• An overview of types of tests and how to understand your results• Breakthrough treatments and medications for hepatitis C, such as triple therapy• The next generation of treatments including interferon-free regimens, QUAD therapy, host-acting antivirals, and more• Personal anecdotes from those affected by hepatitis C

The Most Trusted Resource and Reference for Millions of AmericansLiving with Hepatitis C was the first book to explain in everyday language the causes of this disease, its major and minor symptoms, and all of the latest treatments available. Researchers have continued to make dramatic strides in helping the millions of Americans who suffer from Hepatitis C since the book's first publication, and each new edition has kept up with the most recent findings.The latest revised Living With Hepatitis C, Fifth Edition includes cutting-edge information on:• New treatments including pegylated and consensus interferons• Living-donor transplants• Co-infections with Hepatitis B and HIV/AIDS• Promising new clinical trials of protease and polymerase inhibitors• New maintenance therapies, an expanded and updated resource section, ways to avoid infection, and much moreLiving with Hepatitis C, Fifth Edition is still the'gold standard'resource and reference for those who must endure this disease. It offers guidance and answers for those infected by the virus--and for their spouses, families, and friends.